Journal of pain & palliative care pharmacotherapy Vincent Arcani, Nicolas Fabresse, Guillaume Hache, Anne Donnet Abstract Codeine is a prodrug opioid whose analgesic efficacy depends on its bioactivation into morphine via cytochrome P450 2D6. Its use in migraine is discouraged because of limited
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial
Neurology Rigmor Højland Jensen , Christofer Lundqvist , Henrik W Schytz , Cristina Tassorelli , Fabrizio Vernieri , Michel Lanteri-Minet , Gisela M Terwindt , Andrew Blumenfeld , Stewart J Tepper , Mette Krog Josiassen , Gary Jansson , Anders Ettrup , Aurélia Mittoux , Richard B Lipton Abstract Background and objectives: Medication-overuse headache
Migraine, headache disorders, and brain health: aligning advocacy with the UN Sustainable Development Goals
The journal of headache and pain Paolo Martelletti , Arão Belitardo de Oliveira , Rajinder K Dhamija , Patty Francis , Riadh Gouider , Alla Guekht , Amr Hassan Al-Hasany , Mendinatou Agbetou Houessou , Michel Lanteri-Minet , Matilde Leonardi , Martha Lu-Bolanos , Manoji Pathirage , Abdul Malik , Reza Mosaddeghi-Heris , M
First successful protocol for desensitization to eptinezumab
Headache . 2025 Dec 19. doi: 10.1111/head.70000. Online ahead of print. Benoit Gerard , Hubert Praudel , Michel Lanteri-Minet , Elise Van Obberghen , Fanny Rocher-Moreau , Johanna Rousset , Ulysse Jacquier , Sylvie Leroy , Margot Delin Abstract Background: Eptinezumab is an anti-calcitonin gene-related peptide monoclonal antibody used for
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans
Neurology and therapy 2025 Dec 18. doi: 10.1007/s40120-025-00874-z. Online ahead of print. Peter J Goadsby , Alexandra J Sinclair , Shazia K Afridi , Christian Lucas , Jerôme Mawet , Michel Lanteri-Minet , Xavier Moisset , Hans Christoph Diener , Charly Gaul , Tim Patrick Jürgens , Marja-Liisa Sumelahti , Margarita Sanchez
Migraine-related disability according to headache frequency subclassifications: A systematic review and meta-analysis
Cephalalgia 2025 Oct;45(10):3331024251385965. doi: 10.1177/03331024251385965. Epub 2025 Oct 17. Manjit Singh Matharu , Stephen Silberstein , Hsiangkuo Yuan , Deborah Edgar 3 Roos Colman , Todd J Schwedt , Michel Lanteri-Minet , Mark Obermann Abstract BackgroundThis systematic review and meta-analysis synthesized migraine-related disability outcomes according to headache frequency subclassifications,
Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study
European Journal of Neurology 2025 Aug;32(8):e70328. doi: 10.1111/ene.70328. Stewart J Tepper, David W Dodick, Michel Lanteri-Minet , David Dolezil, Raquel Gil-Gouveia, Christian Lucas, Karolina Piasecka-Stryczynska, Gyöngyi Szabó, Daniel D Mikol, Mahan Chehrenama, Denise E Chou, Zilu Liu, Gabriel Paiva da Silva Lima Abstract Background: Erenumab-induced medication overuse headache (MOH) remission in participants with
Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study
The Journal of Headache and Pain 2025 Jul 2;26(1):153. doi: 10.1186/s10194-025-02086-0. M Lanteri-Minet , C Casarotto, O Bretin, C Collin, M Gugenheim, V Raclot, A Cases, P A Squara, W Aissani, A Saighi, H Lefebvre Abstract Background: The most used treatments for migraine attacks are triptans, yet a considerable proportion of
Validation of an 8-item self-administered questionnaire for assessing migraine-related sensory hypersensitivities (MHQ-8)
The Journal of Headache and Pain 2025 May 26;26(1):128. doi: 10.1186/s10194-025-02067-3. François Gabrielli , Melissa Zuel , Camille Magaud , Sophia Sickout-Arondo , Bruno Pereira , Jérémie Dassa , Solène De Gaalon , Geneviève Demarquay , Anne Donnet , Anne Ducros , Pierric Giraud , Evelyne Guégan-Massardier , Christian Lucas , Jérôme Mawet